Home › Alzheimer's Disease › Tennessee
Alzheimer's Disease clinical trials in Tennessee
16 studies for Alzheimer's Disease are looking for participants at sites in Tennessee.
Cities in Tennessee
Tennessee Alzheimer's Project
- Vanderbilt University Medical Center, Nashville
RecruitingObservational studyHealthy volunteers welcome
Ages 60 and older · All sexes · Updated Nov 10, 2026 · NCT05372172A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease
- Neurology Clinic, P.C., Cordova
RecruitingPhase 3
Ages 60 to 85 · All sexes · Updated Oct 27, 2026 · NCT06976216A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)
- Vanderbilt Psychiatric Hospital, Nashville
RecruitingPhase 3
Ages 55 to 90 · All sexes · Updated Oct 27, 2026 · NCT06585787Alzheimer's Tau Platform: Master Protocol
- Vanderbilt University Medical Center, Nashville
RecruitingPhase 2
Ages 50 to 80 · All sexes · Updated Oct 26, 2026 · NCT06957418Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies
- Genesis Neuroscience Clinic, Knoxville
- K2 Medical Research - Nashville, Nashville
RecruitingPhase 3
Ages 50 to 90 · All sexes · Updated Oct 19, 2026 · NCT07177352A Study of Zunveyl on Safety, Tolerability, Neuropsychiatric Symptoms, and Caregiver Distress in Alzheimer's Disease (RESOLVE)
- Neurology Clinic, P.C., Cordova
RecruitingPhase 4
Ages 50 and older · All sexes · Updated Oct 19, 2026 · NCT07633470Study of LHP588 in Subjects With P. Gingivalis-Positive Alzheimer's Disease
- K2 Medical Research Nashville LLC, Nashville
RecruitingPhase 2
Ages 55 to 80 · All sexes · Updated Oct 7, 2026 · NCT06847321Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986368, for the Treatment of Agitation in Participants With Alzheimer's Disease
- Local Institution - 0031, Chattanooga
- Neurology Clinic, P.C., Cordova
- Vanderbilt University Medical Center- Village, Nashville
RecruitingPhase 2
Ages 55 to 90 · All sexes · Updated Oct 6, 2026 · NCT06808984Randomized Study to Evaluate the Effect of Obicetrapib in Participants With Preclinical Alzheimer's Disease
- K2 Medical Research, Nashville
RecruitingPhase 2
Ages 55 to 85 · All sexes · Updated Sep 28, 2026 · NCT07794670A Study to Assess the Safety and Effects of ABBV-1758 Following Subcutaneous or Intravenous Injections in Participants With Alzheimer's Disease
- Neurology Clinic - Cordova /ID# 277790, Cordova
RecruitingPhase 1/2
Ages 50 to 90 · All sexes · Updated Sep 18, 2026 · NCT07599670A Study to Assess the Effects of ACI-24.060 in Alzheimer's Disease and in Down Syndrome (ABATE Study)
- Neurology Clinical, P.C., Cordova
RecruitingPhase 1/2
Ages 35 to 85 · All sexes · Updated Jul 10, 2026 · NCT05462106Cholinergic Integrity in Down Syndrome in Association With Aging, Alzheimer's Disease Pathology, and Cognition
- Vanderbilt University Medical Center Clinical Research Center, Nashville
RecruitingPhase 2Healthy volunteers welcome
Ages 18 to 55 · All sexes · Updated Jun 22, 2026 · NCT05231798Trial-Ready Cohort-Down Syndrome (TRC-DS)
- Vanderbilt University Medical Center Center for Cognitive Medicine, Nashville
RecruitingObservational study
Ages 25 to 55 · All sexes · Updated May 18, 2026 · NCT04165109Swallowing Impairments in Adults With and Without Alzheimer's Disease
- Vanderbilt University Medical Center, Nashville
RecruitingObservational studyHealthy volunteers welcome
Ages 60 and older · All sexes · Updated May 8, 2026 · NCT06678100Clinical Trial Protocol: Alzheimer's Dementia Underlying Encephalopathy
- Cumberland Medical Center, Crossville
- Roane Medical Center, Harriman
- Fort Sanders Regional Medical Center, Knoxville
- and 3 more
Recruiting
Ages 60 to 90 · All sexes · Updated Oct 29, 2025 · NCT07222280Enhancing Sleep Quality for Nursing Home Residents With Dementia - R33 Phase
- National HealthCare Corporation, Murfreesboro
Recruiting
Ages 50 and older · All sexes · Updated Mar 12, 2024 · NCT05820919From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.